Amer Zeidan/LinkedIn
Sep 6, 2026, 10:51
Amer Zeidan: Looking Ahead to ESH MDS 2026 in Ireland
Amer Zeidan, Chief of Division of Hematologic Malignancies at Yale Comprehensive Cancer Center, Professor of Medicine, Medical Oncology and Hematology at Yale University, shared a post on LinkedIn:
“Looking forward to this excellent meeting on MDS by the European School of Haematology ESH MDS 2026 in Ireland and hope to meet many of you there…”
Stay updated with Hemostasis Today.
-
Oct 21, 2026, 15:35Danny Hsu: Pharma’s 2025 Blockbusters Through a Hematologist’s Lens
-
Oct 21, 2026, 15:12Yue Zhang: Flow Cytometry for Translational Immunology and Cancer Research
-
Oct 21, 2026, 14:58Radoš Stefanović: How Red Blood Cells Adapt After Exercise
-
Oct 21, 2026, 14:08Vera Ghali: The Role of Hepcidin Assays in Diagnosing Iron Disorders
-
Oct 21, 2026, 13:52Negar Asdaghi: Could Cilostazol Improve Hematoma Clearance After ICH
-
Oct 21, 2026, 10:33Karen Schreiber: Beyond Clinical Outcomes – The Voices of Women with APS
-
Oct 21, 2026, 10:11Tau Braun: Clots Through the Copper-Zinc Model
-
Oct 21, 2026, 09:55Cristina Figueroa Villalba: Celebrating Excellence in Transfusion Medicine
-
Oct 21, 2026, 09:43Ahmad Gharehbaghian: How Can Blood Supplies Be Sustained During a Crisis?